The Impact of Medical Insurance Coverage of Imatinib and Molecular Monitoring Frequency on Outcomes in Treatment of Chronic Myeloid Leukaemia (CML)- A Real World Evidence in China
Abstract
Authors
S Chen G Sheng R Zhang M Miao D Wu T Xiong SC Tan C Liu